Showing 1 - 15 results of 15 for search 'Marilena V. Iorio', query time: 0.05s
Refine Results
-
1
-
2
The Therapeutic Potential of MicroRNAs in Cancer: Illusion or Opportunity? by Orazio Fortunato, Marilena V. Iorio
Published 2020-12-01
Article -
3
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review by Marilena V Iorio, Carlo M Croce
Published 2017-06-01
Article -
4
miR-205 in Breast Cancer: State of the Art by Ilaria Plantamura, Alessandra Cataldo, Giulia Cosentino, Marilena V. Iorio
Published 2020-12-01
Article -
5
-
6
-
7
MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer by Alessandra Cataldo, Sandra Romero-Cordoba, Ilaria Plantamura, Giulia Cosentino, Alfredo Hidalgo-Miranda, Elda Tagliabue, Marilena V. Iorio
Published 2020-08-01
Article -
8
-
9
Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation. by Loris De Cecco, Martina Berardi, Michele Sommariva, Alessandra Cataldo, Silvana Canevari, Delia Mezzanzanica, Marilena V Iorio, Elda Tagliabue, Andrea Balsari
Published 2013-01-01
Article -
10
-
11
Mexican <i>Ganoderma Lucidum</i> Extracts Decrease Lipogenesis Modulating Transcriptional Metabolic Networks and Gut Microbiota in C57BL/6 Mice Fed with a High-Cholesterol Diet by Sandra L. Romero-Córdoba, Ivan Salido-Guadarrama, María E. Meneses, Giulia Cosentino, Marilena V. Iorio, Elda Tagliabue, Nimbe Torres, Mónica Sánchez-Tapia, Myrna Bonilla, Ivan Castillo, Beatriz Petlacalco, Armando R. Tovar, Daniel Martínez-Carrera
Published 2020-12-01
Article -
12
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO by Serena Di Cosimo, Chiara M. Ciniselli, Sara Pizzamiglio, Vera Cappelletti, Marco Silvestri, Sarra El-Abed, Miguel Izquierdo, Mohammed Bajji, Paolo Nuciforo, Jens Huober, Jens Huober, David Cameron, Stephen Chia, Henry L. Gomez, Henry L. Gomez, Marilena V. Iorio, Andrea Vingiani, Giancarlo Pruneri, Paolo Verderio
Published 2023-01-01
Article -
13
What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study by Sara Pizzamiglio, Giulia Cosentino, Chiara M. Ciniselli, Loris De Cecco, Alessandra Cataldo, Ilaria Plantamura, Tiziana Triulzi, Sarra El‐abed, Yingbo Wang, Mohammed Bajji, Paolo Nuciforo, Jens Huober, Susan L. Ellard, David L. Rimm, Andrea Gombos, Maria Grazia Daidone, Paolo Verderio, Elda Tagliabue, Serena Di Cosimo, Marilena V. Iorio
Published 2022-01-01
Article -
14
Correction: Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status. by Gianpiero Di Leva, Claudia Piovan, Pierluigi Gasparini, Apollinaire Ngankeu, Cristian Taccioli, Daniel Briskin, Douglas G. Cheung, Brad Bolon, Laura Anderlucci, Hansjuerg Alder, Gerard Nuovo, Meng Li, Marilena V. Iorio, Marco Galasso, Santhanam Ramasamy, Guido Marcucci, Danilo Perrotti, Kimerly A. Powell, Anna Bratasz, Michela Garofalo, Kenneth P. Nephew, Carlo M. Croce
Published 2013-04-01
Article -
15
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. by Gianpiero Di Leva, Claudia Piovan, Pierluigi Gasparini, Apollinaire Ngankeu, Cristian Taccioli, Daniel Briskin, Douglas G Cheung, Brad Bolon, Laura Anderlucci, Hansjuerg Alder, Gerard Nuovo, Meng Li, Marilena V Iorio, Marco Galasso, Ramasamy Santhanam, Guido Marcucci, Danilo Perrotti, Kimerly A Powell, Anna Bratasz, Michela Garofalo, Kenneth P Nephew, Carlo M Croce
Published 2013-01-01
Article